Status:
UNKNOWN
Intermediate and Long Acting Insulin Young Children Type 1 Diabetes.
Lead Sponsor:
Ain Shams University
Conditions:
Type 1 Diabetes Mellitus With Hypoglycemia
type1diabetes
Eligibility:
All Genders
2-5 years
Phase:
PHASE4
Brief Summary
Background: Achieving glycemic control without risking hypoglycemia imposes a major challenge in the management of toddlers and preschool children with Type 1 diabetes(T1D). Optimal insulin therapy fo...
Eligibility Criteria
Inclusion
- Toddlers and preschool children with T1D on insulin therapy
Exclusion
- patients with other medical conditions (i.e. celiac disease or autoimmune thyroiditis), patients with other types of diabetes mellitus (i.e. maturity onset diabetes of youth (MODY) and type 2 diabetes mellitus), patients with history of liver disease or any disorder likely to impair liver functions or elevated liver enzymes, renal impairment due to cause other than diabetes, hypertension, patients taking any vitamins or food supplements one month before study and participation in a previous investigational drug study within 3 months preceding screening.
Key Trial Info
Start Date :
February 21 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 10 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04664764
Start Date
February 21 2019
End Date
March 10 2021
Last Update
February 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt, 11375